Marongiu F, Cauli C, Mariotti S
Policlinico Universitario di Monserrato, University of Cagliari, Cagliari, Italy.
J Endocrinol Invest. 2004 Dec;27(11):1065-71. doi: 10.1007/BF03345311.
The aim of this paper is to briefly review some practical aspects of the relationship between thyroid function and several disorders of the hemostatic system in terms of bleeding and thrombosis. Thrombocytopenia, acquired hemophilia, hypercoagulability, cardioembolism and other biochemical coagulative and fibrinolytic abnormalities have been described in the past years both in hyper- and hypothyroidism. Since most of hyper- and hypothyroid conditions are the consequence of autoimmune thyroid disease (1), either deranged immune function, altered circulating thyroid hormone concentration, or both may concur in the pathogenesis of hemostatic disorders of potential crucial clinical impact. These aspects will be outlined and discussed in an attempt to give answers to some questions, often arising in the clinical approach.
本文旨在从出血和血栓形成的角度,简要回顾甲状腺功能与止血系统的几种疾病之间关系的一些实际情况。过去几年中,无论是甲状腺功能亢进还是减退,均已发现存在血小板减少症、获得性血友病、高凝状态、心源性栓塞以及其他生化性凝血和纤溶异常。由于大多数甲状腺功能亢进和减退情况是自身免疫性甲状腺疾病的结果(1),免疫功能紊乱、循环甲状腺激素浓度改变或两者兼而有之,可能共同参与具有潜在关键临床影响的止血障碍的发病机制。将概述并讨论这些方面,试图回答临床实践中经常出现的一些问题。